NAMI
PRQR icon

Nomura Asset Management International’s ProQR Therapeutics PRQR Stock Holding History

Nomura Asset Management International’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.15M Hold
620,000
– – ﹤0.01% 1190
2026
Q1 		$1M Hold
620,000
– – ﹤0.01% 1108
2025
Q4 		$1.25M Buy
+620,000
New +$1.45M ﹤0.01% 1058

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Nomura Asset Management International's PRQR Position: Q2 2026 in Review

Nomura Asset Management International held its ProQR Therapeutics (PRQR) position steady in Q2 2026 at 620,000 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Nomura Asset Management International first reported a position in PRQR in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.25M in Q4 2025. 70 funds tracked by Wall St. Rank hold PRQR as of Q2 2026.

  • Nomura Asset Management International held 620,000 shares of ProQR Therapeutics worth $1.15M as of Q2 2026.
  • Nomura Asset Management International left its ProQR Therapeutics share count unchanged in Q2 2026.
  • ProQR Therapeutics made up ﹤0.01% of Nomura Asset Management International's portfolio in Q2 2026, its #1190 holding.
  • Nomura Asset Management International first reported a position in ProQR Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Nomura Asset Management International's ProQR Therapeutics position peaked at $1.25M in Q4 2025.
  • 70 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2026.

Based on Nomura Asset Management International's 13F filing for Q2 2026, filed 14 Aug 2026.